A Natural History Study of Patients With G2019S LRRK2 Parkinson's Disease

Clinical trial NCT05349019 · TERMINATED

Trial details

NCT number: NCT05349019
Sponsor: Escape Bio, Inc.
Status: TERMINATED
Study type: OBSERVATIONAL

Patients With Parkinson's Disease (PD) Caused by the p.Gly2019Ser (G2019S) Pathogenic Mutation of the Leucine-Rich Repeat Kinase 2 (LRRK2) Gene

Start date: 2022-05-02
Primary completion: 2022-08-05
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.